FOLD

NASDAQ · Biotechnology

Amicus Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$14.49

+0.00 (+0.00%)

As of Sep 5, 1:27 AM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 6 43%

Hold 8 57%

Sell 0 0%

Price Target

Analyst Price Target +619.5% upside

Low Target $68.91

Average Target $104.26

High Target $125.13

Current Price $14.49

Current
$14.49

Target
$104.26

$68.91 $104.26 avg $125.13

Scenario Analysis

Bear Case

$68.91

375.6%

Low target

Base Case

$104.26

+619.5%

Avg target

Bull Case

$125.13

+763.6%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$14.50

-0.1% from high

52-Week Low

$7.61

+90.4% from low

50-Day SMA

$13.59

+6.6% vs SMA

200-Day SMA

$8.96

+61.7% vs SMA

RSI (14)

72.2

Overbought

Target vs 52W High

$104.26

+619.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.7%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.3%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.8%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-41.0%